Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms of eosinophilic esophagitis
Late-breaking data at 2022 AAAAI Annual Meeting show Dupixent® (dupilumab) significantly improved signs and symptoms…
Mastercam 2026.R2 Delivers GPU-Accelerated Simulation And AI-Powered Assistance
Embedding Governance and Data Privacy into AI-Era Analytics Tools